Pfizer reports positive results from Phase III ulcerative colitis trials of tofacitinib

US drugmaker Pfizer has reported positive results from the first two Phase III trials of tofacitinib in adults with moderately to severely active ulcerative colitis (UC).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news